Smith and Nephew

Article Abstract:

Smith and Nephew has turned around since Chris O'Donnell was appointed as chief executive in 1997, and the company has restructured its board room as well as moving its headquarters to modern premises. The company ranks first in wound management world wide following the acquisition of the collagenase anzyme in Jan 2000 from BASF. The enzyme removes diseased tissue, leaving healthy flesh. The North American market accounted for 40% of the company's sales in 1999, which were over one billion pounds sterling.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Smith and Nephew

Article Abstract:

Smith and Nephew has undergone a restructuring and has sold some consumer brands that were not performing well.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Smith and Nephew

Article Abstract:

Smith and Nephew has seen a rise in its stock price after carrying out a program of restructuring. Stockholders have also benefited from a special dividend.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Medical Instruments and Supplies, Medical Instruments & Equipment, Medical Equipment and Supplies Manufacturing, Medical equipment, Smith and Nephew

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Medical equipment and supplies industry, Medical equipment industry, Smith and Nephew Associated Companies PLC
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.